quinolinic acid has been researched along with carnitine in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ambrose, WW; Breese, GR; Keizer, RF; Kim, CS | 1 |
| Ali, SF; Binienda, Z; Herrera-Mundo, MN; Mendoza-Macedo, K; Pérez-De La Cruz, V; Santamaría, A; Silva-Adaya, D; Villeda-Hernández, J | 1 |
| Ali, SF; Elinos-Calderón, D; Pedraza-Chaverrí, J; Pérez-De La Cruz, V; Robledo-Arratia, Y; Santamaría, A | 1 |
3 other study(ies) available for quinolinic acid and carnitine
| Article | Year |
|---|---|
Effects of 2,4,5-trichlorophenoxyacetic acid and quinolinic acid on 5-hydroxy-3-indoleacetic acid transport by the rabbit choroid plexus: pharmacology and electron microscopic cytochemistry.
Topics: 2,4,5-Trichlorophenoxyacetic Acid; Animals; Biological Transport; Brain; Carnitine; Choroid Plexus; Electron Transport Complex IV; Female; Histocytochemistry; Hydroxyindoleacetic Acid; In Vitro Techniques; Male; Metabolic Clearance Rate; Microscopy, Electron; Pyridines; Quinolinic Acid; Quinolinic Acids; Rabbits; Sodium-Potassium-Exchanging ATPase | 1987 |
Excitotoxic damage, disrupted energy metabolism, and oxidative stress in the rat brain: antioxidant and neuroprotective effects of L-carnitine.
Topics: Animals; Antioxidants; Brain; Carnitine; Convulsants; Disease Models, Animal; Dose-Response Relationship, Drug; Energy Metabolism; Free Radicals; Gliosis; Lipid Peroxidation; Male; Mitochondria; Movement Disorders; Nerve Degeneration; Neurodegenerative Diseases; Neuroprotective Agents; Neurotoxins; Nitro Compounds; Oxidative Stress; Propionates; Quinolinic Acid; Rats; Rats, Wistar; Reactive Oxygen Species; Treatment Outcome | 2008 |
Early nerve ending rescue from oxidative damage and energy failure by L: -carnitine as post-treatment in two neurotoxic models in rat: recovery of antioxidant and reductive capacities.
Topics: Animals; Antioxidants; Brain; Carnitine; Disease Models, Animal; Dose-Response Relationship, Drug; Energy Metabolism; Enzyme Inhibitors; Male; Mitochondria; Neurotoxins; Nitro Compounds; Oxidants; Oxidation-Reduction; Oxidative Stress; Presynaptic Terminals; Propionates; Quinolinic Acid; Rats; Rats, Wistar; Synaptosomes; Vitamin B Complex | 2009 |